OKLAHOMA CITY, Aug. 29, 2017 -- Federman & Sherwood announces that on August 25, 2017, a class action lawsuit was filed in the United States District Court for the Southern District of Florida against PetMed Express, Inc. (NASDAQ:PETS). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is May 8, 2017 through August 23, 2017.
Plaintiff seeks to recover damages on behalf of all PetMed Express, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, October 24, 2017 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or, visit the firm’s website at www.federmanlaw.com


Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
OpenAI Explores Massive Funding Round at $750 Billion Valuation
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



